Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $28.9200 (0.1%) ($28.3100 - $29.2250) on Thu. Oct. 29, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.01% (three month average) | RSI | 56 | Latest Price | $28.9200(0.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.4% a day on average for past five trading days. | Weekly Trend | HALO advances 2.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(48%) IWM(47%) IWC(44%) ARKG(41%) | Factors Impacting HALO price | HALO will decline at least -1.005% in a week (0% probabilities). VIXM(-31%) UUP(-14%) VXX(-13%) EDOC(-5%) IGOV(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.005% (StdDev 2.01%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $29.89(-3.25%) | 10 Day Moving Average | $29.9(-3.28%) | 20 Day Moving Average | $28.88(0.14%) | To recent high | -7% | To recent low | 12.4% | Market Cap | $3.953b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |